Skip to main content
SpringerLink
Log in

Structural neuroimaging of Alzheimer’s disease and other dementias

  • Review Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

This paper reviews the use of imaging techniques to aid in the clinical diagnosis of dementia. Two approaches are distinguished. One is the exclusionary approach in which imaging is used to rule out diseases that would mimic or cause dementia; based on the literature, this approach yields very little, if any, information that was not identified clinically. The more positive approach uses imaging as a diagnostic tool to identify changes specific for causes of dementia; any assessment of medial temporal lobe atrophy on Magnetic Resonance Imaging (MRI) will result in a reasonably high positive likelihood ratio distinguishing AD patients from non-demented individuals, but fails to distinguish AD patients from patients with other dementias. For a diagnosis of vascular dementia imaging is necessary, although not all vascular changes fulfill requirements of being relevant to dementia. Potentially of more importance, given the higher prevalence of AD, is the identification of concomitant vascular changes in AD that may be amenable to therapy, and may be used to identify subgroups. Structural and functional MRI techniques have great potential in identifying patients at risk for AD, which will allow for a very early treatment with drugs that slow or even halt progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ott A., Breteler M.M.B., Van Harskamp F., Claus J.J., Van der Cammen T.J., Grobbee D.E., Hofman A.: Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ 310: 970–973, 1995.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS - ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944, 1984.

    Article  CAS  PubMed  Google Scholar 

  3. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed. 3 revised. American Psychiatric Association, Washington, 1987.

    Google Scholar 

  4. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed. 4. American Psychiatric Association, Washington, 1994.

    Google Scholar 

  5. Chui H., Young Lee A.: Clinical criteria for various dementia subtypes: Alzheimer disease (AD), vascular dementia (VaD), Dementia with Lewy bodies (DLB), and Frontotemporal dementia (FTD). In: Qizilbash N., Schneider L., Chui H., Brodaty H., Kaye J., Erkinjuntti T. (Eds.), Evidence based Dementia. Blackwell Science, Ltd., Oxford, 2001 (in press).

    Google Scholar 

  6. Varma A.R., Snowden J.S., Lloyd J.J., Talbot P.R., Mann D.M.A., Neary D.: Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 66: 184–188, 1999.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., Benson D.F.: Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 51: 1546–1554, 1998.

    Article  CAS  PubMed  Google Scholar 

  8. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., Moody D.M., O’Brien M.D., Yamaguchi T., Grafman J., Drayer B.P., Bennett D.A., Fisher M., Ogata J., Kokmen E., Bermejo F., Wolf P.A., Gorelick P.B., Blick K.L., Pajeau A.K., Bell M.A., DeCarli C., Culebras A., Korczyn A.D., Bogousslavsky J., Hartmann A., Scheinberg P.: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Work Group. Neurology 43: 250–260, 1993.

    Article  PubMed  Google Scholar 

  9. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., Perry R.H.: Consensus guidelines for the clinical and pathologic diagnoses of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47: 1113–1124, 1996.

    Article  CAS  PubMed  Google Scholar 

  10. Farina E., Pomati S., Mariani C.: Observations on dementias with possible reversible symptoms. Aging Clin. Exp. Res. 11: 323–328, 1999.

    Article  CAS  Google Scholar 

  11. Foster G.R., Scott D.A., Payne S.: The use of CT scanning in dementia. A systematic review. Int. J. Technol. Assess. Health Care 15: 406–423, 1999.

    CAS  PubMed  Google Scholar 

  12. Chui H., Zhang Q.: Evaluation of dementia: A systematic study of the usefulness of the American Academy of Neurology practice parameters. Neurology 49: 925–935, 1997.

    Article  CAS  PubMed  Google Scholar 

  13. Waldemar G., Dubois B., Emre M., Scheltens P., Tariska P., Rosor M.N.: Diagnosis and management of Alzheimer’s disease and other disorders associated with dementia. The role of Neurologists in Europe. Eur. J. Neurol. 7: 133–144, 2000.

    Article  CAS  PubMed  Google Scholar 

  14. Jobst K.A., Smith A.D., Barker C.S., Wear A., King E.M., Smith A., Anslow P.A., Molyneux A.J., Shepstone B.J., Soper N., Holmes K.A., Robinson J.R., Hope R.A., Oppenheimer C., Brockbank K., M cDonald B.: Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 55: 190–194, 1992.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. De Leon M.J., George A.E., Stylopoulos L.A., Smith G., Miller D.C.: Early marker for Alzheimer’s disease: the atrophic hippocampus. Lancet II: 672–673, 1989.

    Article  Google Scholar 

  16. De Leon M.J., George A.E., Golomb J., Tarshish C., Convit A., Kluger A., De Santi S., McRae T., Ferris S.H., Reisberg B., Ince C., Rusinek H., Bobinski M., Quinn B., Miller D.C., Wisniewski H.M.: Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease. Neurobiol. Aging 18: 1–11, 1997.

    Article  PubMed  Google Scholar 

  17. Scheltens Ph., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P., Kuiper M., Steinling M., Wolters E.C., Valk J.: Atrophy of medial temporal lobes on MRI in probable Alzheimer’s disease and normal aging: diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 55: 967–972, 1992.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Erkinjuntti T., Lee D.H., Gao F., Steenhuis R., Eliasziw M., Fry R., Merskey H., Hachinski V.C.: Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer’s disease. Arch. Neurol. 50: 305–310, 1993.

    Article  CAS  PubMed  Google Scholar 

  19. Frisoni G.B., Beltramello A., Weiss C., Geroldi C., Bianchetti A., Trabucchi M.: Linear measures of atrophy in mild Alzheimer’s disease. Am. J. Neuroradiol. 17: 913–923, 1996.

    CAS  PubMed  Google Scholar 

  20. O’Brien J.T., Desmond P., Ames D., Schweitzer I., Chiu E., Tress B.: Temporal lobe magnetic resonance imaging can differentiate Alzheimer’s disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychol. Med. 27: 1267–1275, 1997.

    Article  PubMed  Google Scholar 

  21. Scheltens Ph., Launer L.J., Barkhof F., Weinstein H.C., Jonker C.: The diagnostic value of magnetic resonance imaging and Technetium 99m-HMPAO single-photon-emission-computed-tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population. Alzheimer Dis. Assoc. Disord. 11: 63–70, 1997.

    Article  CAS  PubMed  Google Scholar 

  22. Pucci E., Belardinelli N., Regnicolo L., Nolfe G., Signorino M., Salvolini U., Angeleri F.: Hippocampus and parahippocampal gyrus linear measurements based on magnetic resonance in Alzheimer’s disease. Eur. Neurol. 39: 16–25, 1998.

    Article  CAS  PubMed  Google Scholar 

  23. Barber R., Gholkar A., Scheltens Ph., Ballard C., McKeith I.G., O’Brien J.T.: Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 52: 1153–1158, 1999.

    Article  CAS  PubMed  Google Scholar 

  24. Desmond P.M., O’Brien J.T., Tress B.M., Ames D.J., Clement J.G., Clement P., Schweitzer I., Tuckwell V., Robinson G.S.: Volumetric and visual assessment of the mesial temporal structures in Alzheimer’s disease. Aust. N.Z. J. Med. 24: 547–553, 1994.

    Article  CAS  PubMed  Google Scholar 

  25. Wahlund L-O., Julin P., Lindqvist J., Scheltens Ph.: Visual assessment of medial temporal lobe atrophy in demented and healthy controls: correlation with volumetry. Psychiatry Res. 90: 193–199, 1999.

    Article  CAS  PubMed  Google Scholar 

  26. De Leon M.J., Convit A., George A.E., Golomb J., de Santi S., Tarshish C., Rusinek H., Bobinski M., Ince C., Miller D., Wisniewski H.: In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer’s disease. Ann. N.Y. Acad. Sci. 17: 1–13, 1996.

    Article  Google Scholar 

  27. Wahlund L.O., Julin P., Lindqvist J., Scheltens Ph.: Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia. A comparative study. J. Neurol. Neurosurg. Psychiatry 69: 630–635, 2000.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Golomb J., De Leon M.J., Kluger A., George A.E., Tarshish C., Ferris S.H.: Hippocampal atrophy in normal aging. Arch. Neurol. 50: 967–973, 1993.

    Article  CAS  PubMed  Google Scholar 

  29. Scheltens Ph., Launer L.J., Barkhof F., Weinstein H.C., Van Gool W.A.: Visual assessment of medical temporal lobe atrophy on magnetic resonance imaging; interobserver reliability. J. Neurol. 242: 557–560, 1995.

    Article  CAS  PubMed  Google Scholar 

  30. Galton C.J., Gomez-Anson B., Antoun N., Scheltens P., Patterson K., Graves M., Sahakian B.J., Hodges J.R.: Temporal lobe rating scale: application to Alzheimer’s disease and frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry. 70: 165–173, 2001.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R.: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 42: 473–480, 1992.

    Article  CAS  PubMed  Google Scholar 

  32. Jellinger K., Danielczyk W., Fischer P., Gabriel E.: Clinicopathological analysis of dementia disorders in the elderly. J. Neurol. Sci. 95: 239–258, 1990.

    Article  CAS  PubMed  Google Scholar 

  33. Boone K.B., Miller B.L., Lesser J.M., Mehringer C.M., Hill-Gutierrez E., Goldberg M.A., Berman N.G.: Neuropsychological correlates of white matter lesions in healthy elderly subjects. A threshold effect. Arch. Neurol. 49: 549–554, 1992.

    Article  CAS  PubMed  Google Scholar 

  34. Scheltens Ph., Kittner B.: Preliminary Results From An MRI/CT-Based Database for Vascular Dementia and Alzheimer’s Disease. Ann. N.Y. Acad. Sci. 903: 542–547, 2000.

    Article  CAS  PubMed  Google Scholar 

  35. Erkinjuntti T., Inzitari D., Pantoni L., Wallin A., Scheltens P., Rockwood K., Roman G.C., Chui H., Desmond D.W.: Research criteria for subcortical vascular dementia in clinical trials. J. Neural. Transm. 59 (Suppl.) 23–30, 2000.

    CAS  Google Scholar 

  36. Pasquier F., Leys D., Scheltens P.: The influence of coincidental vascular pathology on symptomatology and course of Alzheimer’s disease. J. Neural Transm. 54: 117–127, 1998.

    Article  CAS  Google Scholar 

  37. Massoud F., Devi G., Moroney J.T., Stern Y., Lawton A., Bell K., Marder K., Mayeux R.: The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study. J. Am. Geriatr. Soc. 48: 1204–1210, 2000.

    CAS  PubMed  Google Scholar 

  38. Schroter A., Zerr I., Henkel K., Tschampa H.J., Finkenstaedt M., Poser S.: Magnetic Resonance Imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch. Neurol. 57: 1751–1757, 2000.

    Article  CAS  PubMed  Google Scholar 

  39. Vanneste J.A.: Diagnosis and management of normal-pressure hydrocephalus. J. Neurol. 247: 5–14, 2000.

    Article  CAS  PubMed  Google Scholar 

  40. Fox N.C., Scahill R.I., Crum W.R., Rossor M.N.: Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 52: 1687–1689, 1999.

    Article  CAS  PubMed  Google Scholar 

  41. Fox N.C., Warrington E.K., Rossor M.N.: Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer’s disease. Lancet 353: 21–25, 1999.

    Article  Google Scholar 

  42. Juottonen K., Laakso M.P., Partanen K., Soininen H.: Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. Am. J. Neuroradiol. 20: 139–144, 1999.

    CAS  PubMed  Google Scholar 

  43. Jack C.R. Jr., Petersen R.C., Xu Y.C., Waring S.C., O’Brien P.C., Tangalos E.C., Smith G.E., Ivnik R.J., Kokmen E.: Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49: 786–794, 1997.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Visser P.J., Scheltens Ph., Verhey F.R.J., Schmand B., Launer L.J., Jolles J., Jonker C.: Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J. Neurol. 246: 477–485, 1999.

    Article  CAS  PubMed  Google Scholar 

  45. Rombouts S.A.R.B., Barkhof F., Veltman D.J., Machielsen W.C.M., Witter M.P., Bierlaagh M.A., Lazeron R.H.C., Valk J., Scheltens Ph.: Functional MRI of the (medial) temporal lobe shows decreased neuronal activity in Alzheimer’s disease compared to controls. Am. J. Neuroradiol. 21: 1869–1875, 2000.

    CAS  PubMed  Google Scholar 

  46. Small S.A., Perera G.M., DeLaPaz R., Mayeux R., Stern Y.: Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer’s disease. Ann. Neurol. 45: 466–472, 1999.

    Article  CAS  PubMed  Google Scholar 

  47. Smith C.D., Andersen A.H., Kryscio R.J., Schmitt F.A., Kindy M.S., Blonder L.X., Avison M.J.: Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease. Neurology 53: 1391–1396, 1999.

    Article  CAS  PubMed  Google Scholar 

  48. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W.: Patterns of brain activation in people at risk for Alzheimer’s disease. N. Engl. J. Med. 343: 450–456, 2000.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cognitive Neurology, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands

    Ph. Scheltens M.D., Ph.D.

Authors
  1. Ph. Scheltens M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ph. Scheltens M.D., Ph.D..

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scheltens, P. Structural neuroimaging of Alzheimer’s disease and other dementias. Aging Clin Exp Res 13, 203–209 (2001). https://doi.org/10.1007/BF03351478

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351478

Key words

Search

Navigation